Literature DB >> 2157240

Considerations in fractionated proton radiation therapy: clinical potential and results.

M Austin-Seymour1, M Urie, J Munzenrider, C Willett, M Goitein, L Verhey, R Gentry, P McNulty, A Koehler, H Suit.   

Abstract

Protons have a finite range in tissue and can provide a better concentration of radiation dose in the tumor than conventional X-rays in certain situations. The development of optimized treatment plans for X-rays and protons followed by a comparative evaluation is one method of selecting tumor sites best suited for proton treatment. The preliminary results of comparative treatment planning for base of skull tumors and carcinoma of the prostate are discussed. These comparisons suggest a clinical gain for proton treatment of tumors in these locations. The clinical experience with fractionated proton treatment of several tumor sites is also discussed. The results of high dose proton treatment of chordomas and low grade chondrosarcomas of the base of skull is particularly promising: an actuarial 5-year local control of 78% has been obtained in 50 patients followed for a minimum of 22 months.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157240     DOI: 10.1016/0167-8140(90)90046-y

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

Review 1.  New particles in radiotherapy: an introduction.

Authors:  J M Cosset; M Maher; J L Habrand
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

2.  Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan.

Authors:  Yusuke Demizu; Masashi Mizumoto; Tsuyoshi Onoe; Naoki Nakamura; Yasuhiro Kikuchi; Tetsushi Shibata; Tomoaki Okimoto; Hideyuki Sakurai; Tetsuo Akimoto; Kota Ono; Takashi Daimon; Shigeyuki Murayama
Journal:  Cancer Sci       Date:  2017-04-24       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.